SUM-101

BIOLOGICAL2 trials

Sponsors

European Vaccine Initiative

Conditions

Malaria FeverMalaria,Falciparum

Phase 1

Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso

CompletedNCT06618885

European Vaccine InitiativeMalaria,Falciparum

Start: 2025-08-01End: 2026-04-25Updated: 2026-09-11

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

WithdrawnNCT07124156

European Vaccine InitiativeMalaria Fever

Start: 2026-03-20End: 2026-12-31Updated: 2026-09-11